Ligand Partner GlaxoSmithKline Submits US and European Regulatory Applications for use of PROMACTA/REVOLADE to Increase Platelet Counts in Patients with Hepatitis C May 30, 2012
CORRECTING and REPLACING Ligand to Present at the Jefferies 2012 Global Healthcare Conference on June 4 May 14, 2012
Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17 May 7, 2012
Ligand Presents Full Data from Successful Phase II Trial of Captisol-EnabledĀ®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings February 2, 2012